Literature DB >> 22168177

Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type-specific induction of apoptosis and mitotic catastrophe.

R Cotugno1, R Fortunato, A Santoro, D Gallotta, A Braca, N De Tommasi, M A Belisario.   

Abstract

OBJECTIVES: The aim of this study was to investigate anti-leukaemic potential of coronopilin, a sesquiterpene lactone from Ambrosia arborescens, and to characterize mechanism(s) underlying its activity.
MATERIALS AND METHODS: The study was conducted on Jurkat and U937, two leukaemia-derived cell lines. Apoptosis and impairment of cell cycle progression were evaluated by flow cytometry and by microscopic analysis. Changes in protein expression and activation were evaluated by western blot analysis. Coronopilin-tubulin covalent adducts were demonstrated by mass spectrometry.
RESULTS: Coronopilin inhibited (IC(50) ≤ 20 μm) leukaemia cell population growth, but displayed poor cytotoxicity to normal white blood cells. On Jurkat cells, coronopilin exerted cell population growth inhibition activity, mainly by triggering caspase-dependent apoptosis. Conversely, in U937 cells, coronopilin's primary response was a robust arrest in G(2) /M. Marked increase in mitotic index and presence of activated cyclin B1/Cdk1 complex, phosphorylated histone H3 at Ser10, and hyperpolymerized tubulin indicated that cells accumulated in mitosis. Prolonged mitotic arrest ultimately resulted in U937 mitotic catastrophe, and dying cells exhibited the features of non-caspase-dependent death.
CONCLUSIONS: This study demonstrated that coronopilin efficiently inhibited leukaemia cell population growth by triggering cell type-specific responses. Moreover, coronopilin-mediated cell population expansion inhibition was specific to neoplastic cells, as normal white blood cell viability was not significantly affected. Thus, coronopilin may represent an interesting new chemical scaffold upon which to develop new anti-leukaemic agents.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22168177      PMCID: PMC6496441          DOI: 10.1111/j.1365-2184.2011.00796.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  52 in total

1.  Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation.

Authors:  M E Murnion; R R Adams; D M Callister; C D Allis; W C Earnshaw; J R Swedlow
Journal:  J Biol Chem       Date:  2001-05-11       Impact factor: 5.157

2.  Transcriptional profiling of hematologic malignancies with a low-density DNA microarray.

Authors:  Patricia Alvarez; Pilar Sáenz; David Arteta; Antonio Martínez; Miguel Pocoví; Laureano Simón; Pilar Giraldo
Journal:  Clin Chem       Date:  2006-12-21       Impact factor: 8.327

Review 3.  Targeted anti-mitotic therapies: can we improve on tubulin agents?

Authors:  Jeffrey R Jackson; Denis R Patrick; Mohammed M Dar; Pearl S Huang
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

Review 4.  Mitochondrial membrane permeabilization in cell death.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Catherine Brenner
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

5.  Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

Authors:  Michel Duval; John P Klein; Wensheng He; Jean-Yves Cahn; Mitchell Cairo; Bruce M Camitta; Rammurti Kamble; Edward Copelan; Marcos de Lima; Vikas Gupta; Armand Keating; Hillard M Lazarus; Mark R Litzow; David I Marks; Richard T Maziarz; David A Rizzieri; Gary Schiller; Kirk R Schultz; Martin S Tallman; Daniel Weisdorf
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

6.  Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells.

Authors:  P A Kaufman; J B Weinberg; W C Greene
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro.

Authors:  Jun-Wei Liu; Min-Xia Cai; Ying Xin; Qing-Song Wu; Jun Ma; Po Yang; Hai-Yang Xie; Dong-Sheng Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-08-10

Review 8.  How do anti-mitotic drugs kill cancer cells?

Authors:  Karen E Gascoigne; Stephen S Taylor
Journal:  J Cell Sci       Date:  2009-08-01       Impact factor: 5.285

9.  Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy.

Authors:  Maria Castedo; Jean-Luc Perfettini; Thomas Roumier; Alexander Valent; Hana Raslova; Kenichi Yakushijin; David Horne; Jean Feunteun; Gilbert Lenoir; René Medema; William Vainchenker; Guido Kroemer
Journal:  Oncogene       Date:  2004-05-27       Impact factor: 9.867

Review 10.  GammaH2AX and cancer.

Authors:  William M Bonner; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Olga A Sedelnikova; Stéphanie Solier; Yves Pommier
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

View more
  11 in total

1.  New insights into cell cycle and DNA damage response machineries through high-resolution AMICO quantitative imaging cytometry.

Authors:  A Tarnok; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2013-08-17       Impact factor: 6.831

2.  Anticancer mechanism of 7-α-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells.

Authors:  Siriphorn Chimplee; Carl Smythe; Varomyalin Tipmanee; Suchada Sukrong; Kanyanatt Kanokwiroon
Journal:  PeerJ       Date:  2022-05-27       Impact factor: 3.061

3.  EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells.

Authors:  Fang-Yuan Shao; Sheng Wang; Hong-Yu Li; Wen-Bo Chen; Guo-Cai Wang; Dong-Lei Ma; Nai Sum Wong; Hao Xiao; Qiu-Ying Liu; Guang-Xiong Zhou; Yao-Lan Li; Man-Mei Li; Yi-Fei Wang; Zhong Liu
Journal:  Oncotarget       Date:  2016-02-09

4.  Repeated-dose toxicity of common ragweed on rats.

Authors:  Tivadar Kiss; Andrea Szabó; Gábor Oszlánczi; Anita Lukács; Zoltán Tímár; László Tiszlavicz; Dezső Csupor
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

5.  MEDICINAL PLANTS USED IN TRADITIONAL HERBAL MEDICINE IN THE PROVINCE OF CHIMBORAZO, ECUADOR.

Authors:  Fátima Morales; Susana Padilla; Félix Falconí
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-11-23

6.  Sesquiterpene lactone! a promising antioxidant, anticancer and moderate antinociceptive agent from Artemisia macrocephala jacquem.

Authors:  Mohammad Shoaib; Ismail Shah; Niaz Ali; Achyut Adhikari; Muhammad Nawaz Tahir; Syed Wadood Ali Shah; Saiqa Ishtiaq; Jahangir Khan; Shahzeb Khan; Mohammad Naveed Umer
Journal:  BMC Complement Altern Med       Date:  2017-01-07       Impact factor: 3.659

Review 7.  Emerging Anti-Mitotic Activities and Other Bioactivities of Sesquiterpene Compounds upon Human Cells.

Authors:  Alessandra Bosco; Roy M Golsteyn
Journal:  Molecules       Date:  2017-03-13       Impact factor: 4.411

8.  Molecular Mechanisms Underlying Yatein-Induced Cell-Cycle Arrest and Microtubule Destabilization in Human Lung Adenocarcinoma Cells.

Authors:  Shang-Tse Ho; Chi-Chen Lin; Yu-Tang Tung; Jyh-Horng Wu
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

9.  Isolation of a natural product with anti-mitotic activity from a toxic Canadian prairie plant.

Authors:  Layla Molina; David E Williams; Raymond J Andersen; Roy M Golsteyn
Journal:  Heliyon       Date:  2021-05-24

10.  Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells.

Authors:  Siriphorn Chimplee; Sittiruk Roytrakul; Suchada Sukrong; Theera Srisawat; Potchanapond Graidist; Kanyanatt Kanokwiroon
Journal:  Molecules       Date:  2022-01-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.